Breakthroughs in the medical application of methyl silicone oil and environmental protection policies drive industry transformation

1. New option for ophthalmic surgery: Short-term methyl silicone oil filling enhances postoperative outcomes
Multicenter clinical studies have shown that the postoperative retinal structure recovery of patients undergoing retinal detachment surgery with methyl silicone oil filling for one month is better than that of patients with long-term filling. The data show that the central macular thickness (CMT) and the thickness of the ganglion cell layer - inner plexiform layer (GCL-IPL) in the 1-month filling group were significantly higher than those in the 3-month and 6-month filling groups, and the intraocular pressure control was more stable. This discovery provides a new treatment strategy for ophthalmic surgery, which can effectively reduce postoperative complications and improve the quality of life of patients.

2. Optimization of gastroscopy: Precise use of methyl silicone oil shortens the operation time
In the field of digestive system disease diagnosis, the application strategy of methyl silicone oil has been further optimized. Randomized controlled trials have shown that taking methyl silicone oil 20 to 30 minutes before the examination can significantly shorten the operation time of gastroscopy and increase the detection rate of gastric mucosal lesions by 30%. Its anti-foaming effect can quickly remove mucus and bubbles in the stomach, providing doctors with a clear vision and reducing the risk of missed diagnosis. This standardized operation procedure has been incorporated into multiple clinical guidelines and has become a routine preparation step for gastroscopy.

3. New carbon footprint regulations come into effect: The methyl silicone oil industry initiates full life cycle management
The group standard "Quantification Methods and Requirements for Carbon Footprint of Greenhouse Gas Products" to be implemented in 2025 will incorporate the production of methyl silicone oil into the full life cycle accounting system. This standard requires enterprises to track carbon emissions throughout the entire chain from silicon ore mining to product application, and achieve precise carbon footprint management by optimizing process parameters and energy structure. A leading enterprise has reduced carbon emissions per ton of methyl silicone oil by 22% and wastewater discharge by 35% through technological transformation. This policy has forced the industry to accelerate its green transformation. It is expected that the number of green product certification enterprises will exceed 50 by 2025.

4. Medical-grade methyl silicone oil: A Leap from Excipients to drug carriers
The application scope of pharmaceutical-grade methyl silicone oil is constantly expanding and has been upgraded from a traditional lubricant to a drug carrier. Its biocompatibility and sustained-release properties make it perform exceptionally well in transdermal drug delivery systems, extending the drug release time to over 24 hours and reducing blood drug concentration fluctuations by 40%. Meanwhile, the development of nano-scale methyl silicone oil has provided a new approach for targeted therapy. Its smaller particle size can enhance the penetration ability of drugs into tumor tissues. With the improvement of the "Pharmacopoeia Quality Standard for Pharmaceutical Grade Dimethyl Silicone Oil", the market size in this field is expected to grow at an average annual rate of 15%.